Showing results (21-30 of 819) with videos related to
Sort By:
Pageof 82
International Journal of Clinical Practice. Supplement|April 3, 2003
Preclinical safety profile of alendronateC Peter, G A RodanAnnals of Medicine|August 1, 1993
Bisphosphonates in the treatment of metabolic bone diseasesG A Rodan, R BalenaMolecular Endocrinology (Baltimore, Md.)|August 1, 1991
Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional controlM Ernst, G A RodanScience (New York, N.Y.)|September 1, 2000
Therapeutic approaches to bone diseasesG A Rodan, T J MartinCalcified Tissue International|September 1, 1990
A model for investigating the local action of bone-acting agents in vivo: effects of hPTH(1-34) on the secondary spongiosa in the ratT Takano-Yamamoto, G A RodanThe Journal of Biological Chemistry|April 10, 1982
The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cellsR J Majeska, G A RodanProceedings of the National Academy of Sciences of the United States of America|June 1, 1976
Interrelationships between Ca2+ and adenylate and guanylate cyclases in the control of platelet secretion and aggregationG A Rodan, M B FeinsteinJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1988
Indomethacin inhibition of tenotomy-induced bone resorption in ratsD D Thompson, G A RodanCell Motility and the Cytoskeleton|November 1, 2000
PYK2 is an adhesion kinase in macrophages, localized in podosomes and activated by beta(2)-integrin ligationL T Duong, G A RodanPageof 82